Study shows no association between the use of protein supplements and semen quality characteristics

On the 6th of May, Fertility & Sterility under the American Society of Reproductive Medicine published the study, which used data from the Fetal Programming of Semen Quality (FEPOS) cohort, co-funded by ReproUnion.

ReproUnion researchers successfully defend their PhD projects

Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. In 2015-18 ReproUnion supported 24 research projects.

microRNAs can be potential new markers of testicular cancer

On the 10th of March, ReproUnion researchers, Nina Mørup and Kristian Almstrup published a review article in the prominent journal Nature Reviews Urology. The authors summarise how microRNAs can be potential new markers of testicular cancer.

Patient mobility agreement continues to offer cross-border reproductive treatments

One of the highlights for ReproUnion in 2019 was the renewal of the patient mobility agreement between the Capital Region of Denmark and Region Skåne. This will enable more patients to receive specialized reproductive treatment across the Danish/Swedish border.

Collaboration needed to turn around the negative fertility trend

Regional Chairmen and Deans in Lund, Malmö and Copenhagen stand behind ReproUnion in this opinion article, which Dagens Medicin in Sweden published in December 2019. It,highlights the concerning infertility statistics, as well as the need to continue involving new collaboration partners to address prevention and develop new reproductive treatments. Click on to read the full article (in Swedish).

With 1000 young men enrolled, FEPOS is the world largest cohort to examine the fetal origin of adult semen quality

FEPOS investigates the possible causes between male infertility and what was passed on at the fetal stage, by paring samples from mothers and their sons. Data from 100.000 mothers originates from the Danish National Birth Cohort and since 2017 FEPOS has collected biological samples and data from 1000 sons.

Partnership Agreement signed for ReproUnion 2.0

ReproUnion 2.0 marks the beginning of a new research and innovation paradigm within reproductive medicine in Greater Copenhagen. With seven signatures on the formal agreement, the partnership stands ready to continuously use the regional innovation force, international collaboration partners, and the triple-helix structure as leverage in its effort to solve five major global reproductive challenges, which are of great individual and social concern.

Fifty delegates attend the first ReproUnion 2.0 Research Seminar

The seminar on the 11th of November featured regional and international speakers within reproductive medicine. Professors involved in ReproUnion presented the five challenges they work with in the project. This includes the ReproUnion Infertility Cohort and Biobank, which is a collaboration between the three challenge groups, working to improve human male fertility; optimize medically assisted reproductive treatment and prevent infertility-related morbidity.

ReproUnion explores new funding opportunities and research networks

In November, ReproUnion had invited international colleagues from the EU and the US, to discuss collaboration and to attend a weekend-workshop on funding opportunities for the ReproUnion Infertility Cohort and Biobank.

The end of babies..

Something is stopping us from creating the families we claim to desire. But what? This opinion piece in the New York Times gets well around the declining fertility rates and the topic of fertility awareness. The article brings examples from Denmark and quotes Dr. Søren Ziebe, ReproUnion Challenge 5.

Comments are closed.

Close Search Window